Home » Topics » Regulatory » Patents

Patents
RSS

Cephalon reports K-252a derivatives for neurology indications

March 12, 1998

Vasopressin antagonists for treating CHF

March 12, 1998

Novel immunomodulatory agents described by Takeda

March 12, 1998

Antithrombotics developed at Warner-Lambert

March 12, 1998

New antitumor and immunosuppressive compounds in development at Klinge

March 12, 1998

Rhone-Poulenc Rorer synthesizes and evaluates new TNF/cAMP PDE inhibitors

March 12, 1998

P&U scientists disclose new MMP inhibitors for connective tissue diseases

March 12, 1998

Inhibitors of cholesterol biosynthesis under study at Pfizer

March 11, 1998

Antimigraine agent for nasal or oral administration disclosed by Pierre Fabre

March 11, 1998

SmithKline Beecham claims indolines for CNS disorders

March 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...